Skip to main content

Peer Review reports

From: Discovery of a novel ALK/ROS1/FAK inhibitor, APG-2449, in preclinical non-small cell lung cancer and ovarian cancer models

Original Submission
10 Feb 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
5 Apr 2022 Reviewed Reviewer Report
27 Apr 2022 Reviewed Reviewer Report
17 May 2022 Author responded Author comments - Yifan Zhai
Resubmission - Version 4
17 May 2022 Submitted Manuscript version 4
25 May 2022 Author responded Author comments - Yifan Zhai
Resubmission - Version 5
25 May 2022 Submitted Manuscript version 5
26 May 2022 Author responded Author comments - Yifan Zhai
Resubmission - Version 6
26 May 2022 Submitted Manuscript version 6
Publishing
31 May 2022 Editorially accepted
11 Jul 2022 Article published 10.1186/s12885-022-09799-4

You can find further information about peer review here.

Back to article page